JP2019510027A5 - - Google Patents

Download PDF

Info

Publication number
JP2019510027A5
JP2019510027A5 JP2018550333A JP2018550333A JP2019510027A5 JP 2019510027 A5 JP2019510027 A5 JP 2019510027A5 JP 2018550333 A JP2018550333 A JP 2018550333A JP 2018550333 A JP2018550333 A JP 2018550333A JP 2019510027 A5 JP2019510027 A5 JP 2019510027A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
pharmaceutically acceptable
compound
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018550333A
Other languages
English (en)
Japanese (ja)
Other versions
JP6931357B2 (ja
JP2019510027A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/057663 external-priority patent/WO2017167953A1/en
Publication of JP2019510027A publication Critical patent/JP2019510027A/ja
Publication of JP2019510027A5 publication Critical patent/JP2019510027A5/ja
Application granted granted Critical
Publication of JP6931357B2 publication Critical patent/JP6931357B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018550333A 2016-03-31 2017-03-31 デングウイルス複製阻害剤としての置換インドリン誘導体 Active JP6931357B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16163281 2016-03-31
EP16163281.5 2016-03-31
PCT/EP2017/057663 WO2017167953A1 (en) 2016-03-31 2017-03-31 Substituted indoline derivatives as dengue viral replication inhibitors

Publications (3)

Publication Number Publication Date
JP2019510027A JP2019510027A (ja) 2019-04-11
JP2019510027A5 true JP2019510027A5 (enExample) 2019-05-23
JP6931357B2 JP6931357B2 (ja) 2021-09-01

Family

ID=55646444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018550333A Active JP6931357B2 (ja) 2016-03-31 2017-03-31 デングウイルス複製阻害剤としての置換インドリン誘導体

Country Status (20)

Country Link
US (1) US10913716B2 (enExample)
EP (1) EP3436436B1 (enExample)
JP (1) JP6931357B2 (enExample)
KR (1) KR102359735B1 (enExample)
CN (1) CN109195949B (enExample)
AU (1) AU2017240077A1 (enExample)
BR (1) BR112018069601A2 (enExample)
CA (1) CA3013407A1 (enExample)
CL (1) CL2018002718A1 (enExample)
CO (1) CO2018008421A2 (enExample)
CR (1) CR20180496A (enExample)
EA (1) EA201892216A1 (enExample)
EC (1) ECSP18073366A (enExample)
ES (1) ES2923771T3 (enExample)
IL (1) IL261943A (enExample)
MA (1) MA44498A (enExample)
MX (1) MX2018011788A (enExample)
PH (1) PH12018502016A1 (enExample)
SG (1) SG11201808270PA (enExample)
WO (1) WO2017167953A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201116559D0 (en) 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
GB201305376D0 (en) 2013-03-25 2013-05-08 Univ Leuven Kath Novel viral replication inhibitors
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20160198B1 (ar) 2015-09-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JO3633B1 (ar) 2015-09-16 2020-08-27 Katholieke Univ Leuven Ku Leuven Research & Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
MA44498A (fr) 2016-03-31 2019-02-06 Janssen Pharmaceuticals Inc Dérivés d'indoline substituée utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue
SG11201808138YA (en) 2016-03-31 2018-10-30 Janssen Pharmaceuticals Inc Substituted indole derivatives as dengue viral replication inhibitors
JOP20170069B1 (ar) 2016-04-01 2021-08-17 1 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
EP3436004B1 (en) 2016-04-01 2024-12-11 Janssen Pharmaceuticals, Inc. Substituted indole compound derivatives as dengue viral replication inhibitors
JOP20180026A1 (ar) * 2017-03-31 2019-01-30 Univ Leuven Kath مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180025B1 (ar) 2017-03-31 2021-08-17 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
SI3630724T1 (sl) 2017-05-22 2021-08-31 Janssen Pharmaceuticals, Inc. Substituirani derivati indolina kot zaviralci replikacije virusa denga
CA3060583C (en) 2017-05-22 2024-06-04 Janssen Pharmaceuticals, Inc. Substituted indoline derivatives as dengue viral replication inhibitors
CN109485596A (zh) * 2018-12-19 2019-03-19 山东理工职业学院 一种含吲哚啉的登革病毒抑制剂的制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001520998A (ja) 1997-10-27 2001-11-06 イーライ・リリー・アンド・カンパニー インドールsPLA2阻害剤のモルホリノ−N−エチルエステルプロドラッグ
GB0110832D0 (en) 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
JP2005520795A (ja) 2001-12-12 2005-07-14 コンフォーマ・セラピューティクス・コーポレイション Hsp90阻害活性を有するプリン類似体
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
US20060211698A1 (en) 2005-01-14 2006-09-21 Genelabs, Inc. Bicyclic heteroaryl derivatives for treating viruses
AU2006221080A1 (en) 2005-02-09 2006-09-14 Migenix Inc. Compositions and methods for treating or preventing flaviviridae infections
AU2009256390A1 (en) 2008-06-03 2009-12-10 Siga Technologies, Inc. Small molecule inhibitors for the treatment or prevention of dengue virus infection
TWI614024B (zh) * 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8143259B2 (en) 2008-08-19 2012-03-27 Janssen Pharmaceutica, Nv Cold menthol receptor antagonists
TWI453207B (zh) 2008-09-08 2014-09-21 Signal Pharm Llc 胺基三唑并吡啶,其組合物及使用其之治療方法
WO2010091413A1 (en) 2009-02-09 2010-08-12 Enanta Pharmaceuticals, Inc. Linked dibenzimidazole derivatives
GB0910003D0 (en) 2009-06-11 2009-07-22 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases
US8993604B2 (en) 2009-06-30 2015-03-31 Siga Technologies, Inc. Treatment and prevention of dengue virus infections
KR20120123678A (ko) 2010-01-15 2012-11-09 길리애드 사이언시즈, 인코포레이티드 플라비비리다에 바이러스의 억제제
US20130023532A1 (en) 2010-03-26 2013-01-24 Casillas Linda N Indazolyl-pyrimidines as kinase inhibitors
JP5716205B2 (ja) 2011-03-29 2015-05-13 学校法人日本大学 グルコシダーゼ活性阻害用組成物及びそのスクリーニング方法
GB201116559D0 (en) * 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
GB201305376D0 (en) 2013-03-25 2013-05-08 Univ Leuven Kath Novel viral replication inhibitors
MX368158B (es) 2013-10-23 2019-09-20 Janssen Sciences Ireland Uc Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b.
KR20240017118A (ko) 2014-01-31 2024-02-06 브리스톨-마이어스 스큅 컴퍼니 인자 XIa 억제제로서의 헤테로시클릭 P2' 기를 갖는 마크로사이클
PT3201176T (pt) 2014-10-01 2019-03-04 Janssen Pharmaceuticals Inc Derivados indol mono- ou dissubstituídos como inibidores da replicação viral do dengue
NO2721243T3 (enExample) 2014-10-01 2018-10-20
DK3201177T3 (en) 2014-10-01 2019-03-04 Janssen Pharmaceuticals Inc MONO OR DISUBSTITUTED INDOLES AS INHIBITORS OF DENGUE VIRUS REPLICATION
PH12017501272B1 (en) 2015-01-16 2023-01-11 Janssen Pharmaceuticals Inc Indole derivatives as dengue viral replication inhibitors
AR103680A1 (es) 2015-02-23 2017-05-24 Lilly Co Eli Inhibidores selectivos de bace1
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JO3633B1 (ar) 2015-09-16 2020-08-27 Katholieke Univ Leuven Ku Leuven Research & Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20160198B1 (ar) 2015-09-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
EP3370698B1 (en) 2015-11-03 2022-01-26 Zoetis Services LLC Sol-gel polymer composites and uses thereof
SG11201808138YA (en) 2016-03-31 2018-10-30 Janssen Pharmaceuticals Inc Substituted indole derivatives as dengue viral replication inhibitors
MA44498A (fr) 2016-03-31 2019-02-06 Janssen Pharmaceuticals Inc Dérivés d'indoline substituée utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue
MY194647A (en) 2016-03-31 2022-12-09 Takeda Pharmaceuticals Co Heterocyclic compound
KR102608405B1 (ko) 2016-04-01 2023-12-01 카이트 파마 인코포레이티드 키메라 수용체 및 그의 사용 방법
US10603380B2 (en) 2016-04-01 2020-03-31 Kite Pharma, Inc. Chimeric antigen and T cell receptors and methods of use
CA3015934A1 (en) 2016-04-01 2017-10-05 Basf Se Bicyclic compounds
EP3436004B1 (en) 2016-04-01 2024-12-11 Janssen Pharmaceuticals, Inc. Substituted indole compound derivatives as dengue viral replication inhibitors
JOP20170069B1 (ar) * 2016-04-01 2021-08-17 1 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
KR102694879B1 (ko) 2016-04-01 2024-08-16 암젠 인크 Flt3에 대한 키메라 수용체 및 이의 사용 방법
BR112018070163A2 (pt) 2016-04-01 2019-01-29 Signal Pharm Llc compostos de aminopurina substituída, composições e métodos de tratamento
JOP20180026A1 (ar) 2017-03-31 2019-01-30 Univ Leuven Kath مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180025B1 (ar) 2017-03-31 2021-08-17 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
SI3630724T1 (sl) 2017-05-22 2021-08-31 Janssen Pharmaceuticals, Inc. Substituirani derivati indolina kot zaviralci replikacije virusa denga
CA3060583C (en) 2017-05-22 2024-06-04 Janssen Pharmaceuticals, Inc. Substituted indoline derivatives as dengue viral replication inhibitors
CN109485596A (zh) * 2018-12-19 2019-03-19 山东理工职业学院 一种含吲哚啉的登革病毒抑制剂的制备方法

Similar Documents

Publication Publication Date Title
JP2019510034A5 (enExample)
JP2017531619A5 (enExample)
HRP20211278T1 (hr) Supstituirani derivati indolina kao inhibitori replikacije denga virusa
JP2018515495A5 (enExample)
JP2019501879A5 (enExample)
JP2015537020A5 (enExample)
HRP20200408T1 (hr) Mono- ili di-supstituirani derivati indola kao inhibitori replikacije denga virusa
JP2019524883A5 (enExample)
JP2013518107A5 (enExample)
JP2020097577A5 (enExample)
JP2016508134A5 (enExample)
JP2016515561A5 (enExample)
JP2017523169A5 (enExample)
RU2012117829A (ru) Фосфорамидатные производные нуклеозидов
HRP20202051T1 (hr) Aril supstituirani pirimidini za uporabu kod infekcije virusom influence
JP2015024998A5 (enExample)
JP2017511360A5 (enExample)
RU2015109132A (ru) Пролекарственная форма тенофовира и ее фармацевтические применения
JP2014521688A5 (enExample)
BR112014001798A2 (pt) compostos de tetraciclina 9-aminometila substituídos
JP2015508103A5 (enExample)
HRP20210847T1 (hr) Supstituirani derivati indola kao inhibitori replikacije denga virusa
JP2014511892A5 (enExample)
JP2020507589A5 (enExample)
JP2017517565A5 (enExample)